You just read:

Regen BioPharma, Inc. Receives New Preliminary HemaXellerate Clinical Data on Bone Marrow Suppression from Pan Am Cancer Treatment Center

News provided by

Regen BioPharma Inc.

Aug 16, 2016, 08:00 ET